Cargando…
Successful pulsed methylprednisolone and convalescent plasma treatment in a case of a renal transplant recipient with COVID-19 positive pneumonia: a case report
Coronavirus 2019 disease (COVID-19) is a deadly disease that was first seen in Wuhan, China, and primarily affects the respiratory system, but also has different systemic involvements. It has caused 89 million cases and 1.9 million deaths worldwide. COVID-19 positive renal transplant recipients have...
Autores principales: | Bayrak, Muharrem, Çadirci, Kenan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179983/ https://www.ncbi.nlm.nih.gov/pubmed/34122700 http://dx.doi.org/10.11604/pamj.2021.38.273.28577 |
Ejemplares similares
-
Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia
por: Jamir, Imtiakum, et al.
Publicado: (2020) -
Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children
por: Tamura, Akihiro, et al.
Publicado: (2008) -
PULSED METHYLPREDNISOLONE USAGE IN ARDS DUE TO VIRAL PNEUMONIA
por: Szeto, C.H.
Publicado: (2019) -
Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children
por: You, Sun Young, et al.
Publicado: (2014) -
Retrospective comparison of convalescent plasma with continuing high‐dose methylprednisolone treatment in SARS patients
por: Soo, Y. O. Y., et al.
Publicado: (2004)